Shares of Citius Pharmaceuticals, a small company developing critical care products, plunged nearly 40% to an all-time low on Friday, November 15. The trigger was an announced direct offering at $0.25 per share. Details Citius Pharmaceuticals stock dropped almost 40% on the Nasdaq to a record-low of $0.20 per share…